Strategic partnerships Synexa has a history of collaborations and acquisitions (Waters collaboration, Alderley Analytical acquisition, Parexel partnership, CEPI membership). This indicates openness to alliance-led growth and expanded service capabilities, suggesting sales opportunities around joint projects, co-marketing, and integration of complementary bioanalytical offerings.

Global lab footprint With three laboratories in Manchester, Cape Town, and Turku and a global reach, there is potential to upsell cross-location testing, standardize globally, and offer multicenter studies, enabling clients to run trials across regions with a single partner.

Biomarker and tech leadership Deep expertise in biomarker development, large and small molecule bioanalysis, and a broad tech stack (MSD, LC-MS/MS, ELISA, flow cytometry, ELISpot, and genetics services) positions Synexa to pursue complex translational studies and high-end analytics, appealing to sponsors needing robust, custom assays.

Sustainability emphasis Recent Green Lab Certification milestone signals a commitment to sustainability. This can be leveraged to target clients with ESG goals and to offer sustainable lab practices as a competitive differentiator in bids and renewals.

Growth through integrations Active use of CRM and marketing tech (Salesforce, Adobe Experience Cloud, LinkedIn Ads, Microsoft Advertising) combined with recent capacity expansion (acquisition) suggests readiness for scalable sales efforts, integrated client journeys, and targeted outreach to large biotech and pharma companies seeking biomarker services.